Editorial: Biomarkers and therapeutic strategies in acute lymphoblastic leukemia
Authors:
Open Access
- 17 May 2023
- journal article
- editorial
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 11, 1211569
Abstract
Editorial: Biomarkers and therapeutic strategies in acute lymphoblastic leukemiaKeywords
This publication has 5 references indexed in Scilit:
- Precision Oncology: 2022 in ReviewCancer Discovery, 2022
- HAP1 loss confers l-asparaginase resistance in ALL by downregulating the calpain-1-Bid-caspase-3/12 pathwayBlood, 2019
- Genome-wide loss-of-function genetic screening identifies opioid receptor μ1 as a key regulator of L-asparaginase resistance in pediatric acute lymphoblastic leukemiaOncogene, 2017
- Acute Lymphoblastic Leukemia in ChildrenNew England Journal of Medicine, 2015
- Treatment of Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2006